Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Hyalex MTP Study

The HYALEX SLALOM MTP Hemiarthroplasty System consists of a synthetic implant designed to replace the distal metatarsal surface of the great toe for treatment of arthritis . The system is composed of the HYALEX MTP Implant and instrumentation. The implant consists of the HYALEX Cartilage material bonded to a titanium backing.

Participants needed: 20
Trial details
Age: 21-75Biological sex: AllType: InterventionalSponsor: Hyalex Orthopaedics, Inc.Updated: Apr 20, 2026Locations: 1
Eligibility criteria

21-75 years; [+4]

Known allergy to polyurethanes, bone cement, acrylic, or titanium; [+10]

Status: Recruiting

The HYALEX Pivotal Study

A multicenter, open-label, single-arm, pivotal study to evaluate the safety and effectiveness of the HYALEX Freestyle Resurfacing System for replacement of loss of articular cartilage and bone of the knee femoral condyles in symptomatic patients who require surgical treatment, will be enrolled in the study and undergo implantation of the HYALEX Freestyle Resurfacing Implant.

Participants needed: 85
Trial details
Age: 22-70Biological sex: AllType: InterventionalSponsor: Hyalex Orthopaedics, Inc.Updated: Apr 16, 2026Locations: 4
Eligibility criteria

22-70 years. [+6]

Known allergy to polyurethanes, bone cement, acrylic, or titanium. [+16]

Status: Recruiting

The Hyalex First-in-Human Study

The Hyalex First-in-Human Study is a prospective, multicenter, open-label, single-arm, 2-phase, first-in-human study to evaluate the safety and technical performance of the HYALEX Knee Cartilage System for replacement of loss of articular cartilage and bone of the knee femoral condyles in symptomatic patients who require surgical treatment.

Participants needed: 15
Trial details
Age: 21-65Biological sex: AllType: InterventionalSponsor: Hyalex Orthopaedics, Inc.Updated: Jun 29, 2025Locations: 2
Eligibility criteria

Phase 1 [+14]

Phase 1 & 2 [+19]